FrancophonIA/ELRC3.0 huggingface dataset:
English: In patients with renal impairment in whom mycophenolate mofetil and ganciclovir or its prodrugs, e.g. valganciclovir, are co-administered the dose recommendations for ganciclovir should be observed and patients monitored carefully.
Croatian: Kod bolesnika s oštećenjem bubrega kod kojih se istodobno primjenjuju mofetilmikofenolat i ganciklovir ili njegovi predlijekovi, npr. valganciklovir,
English: Mycophenolate mofetil Teva 500 mg film-coated tablets
Croatian: Mikofenolat mofetil Teva 500 mg filmom obložene tablete.
English: In patients with renal impairment in whom Mycophenolate mofetil Teva and ganciclovir or its prodrugs, e.g. valganciclovir, are co-administered the dose recommendations for ganciclovir should be observed and patients monitored carefully.
Croatian: Kod bolesnika s oštećenjem bubrega kod kojih se istodobno primjenjuju Mikofenolat mofetil Teva i ganciklovir ili njegovi predlijekovi, npr.
English: Therefore, a change in the dose of Mycophenolate mofetil Teva should not normally be necessary in the absence of clinical evidence of graft dysfunction.
Croatian: Stoga, ako nema kliničkih dokaza disfunkcije presatka, promjena doze mofetilmikofenolata obično nije potrebna.
English: Teva.
Croatian: Vašem slučaju.
English: Mycophenolate mofetil Teva should be administered with caution in patients with active serious digestive system disease.
Croatian: Mikofenolat mofetil Teva ne smije se davati bolesnicima s preosjetljivošću na mofetilmikofenolat,
English: Pneumonia, influenza, respiratory tract infection, respiratory moniliasis, gastrointestinal infection, candidiasis, gastroenteritis, infection, bronchitis,
Croatian: Poremećaji probavnog sustava vrlo često povraćanje, bol u abdomenu, proljev, mučnina često gastrointestinalno krvarenje, peritonitis, ileus, kolitis,
English: You must not donate blood during treatment with Mycophenolate mofetil Teva and for at least 6 weeks after stopping treatment.
Croatian: Tijekom liječenja lijekom Mikofenolat mofetil Teva i najmanje 6 tjedana nakon prestanka liječenja ne smijete darivati krv.
English: • Before you start taking Mycophenolate mofetil Teva
Croatian: To uključuje: • razdoblje prije početka uzimanja lijeka Mikofenolat mofetil Teva
English: Each dose must be taken with food.
Croatian: Svaka se doza mora uzeti s hranom.
English: For adults, the recommended dose is 300 mg once a day.
Croatian: Preporučena doza za odrasle osobe je 300 mg jedanput na dan.
English: Further information on Atazanavir Krka can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/atazanavir-krka.
Croatian: Više informacija o lijeku Atazanavir Krka nalazi se na internetskim stranicama Agencije: ema.europa.eu/medicines/human/EPAR/atazanavir-krka.
English: This allows a lower dose of atazanavir to be used for the same antiviral effect.
Croatian: To omogućuje da se manja doza atazanavira primjenjuje za postizanje istih antivirusnih učinaka.
English: Atazanavir Krka is available as capsules (150 mg, 200 mg and 300 mg).
Croatian: Lijek je dostupan u obliku kapsula (150 mg, 200 mg i 300 mg).
English: It is used together with low-dose ritonavir and other antiviral medicines to treat patients aged 6 years and over.
Croatian: Primjenjuje se zajedno s niskom dozom ritonavira i drugih protuvirusnih lijekova za liječenje bolesnika u dobi od šest godina i starijih.
English: It can only be obtained with a prescription and treatment should be started by a doctor who has experience in the treatment of HIV infection.
Croatian: Lijek se izdaje samo na liječnički recept, a liječenje mora započeti liječnik s iskustvom u liječenju infekcije HIV-om.
English: Blocking the enzyme prevents the virus from multiplying, slowing down the spread of infection.
Croatian: Blokiranjem enzima sprečava se umnožavanje virusa, što usporava širenje infekcije.
English: Atazanavir Krka is normally given with ritonavir to boost its action but doctors can consider stopping ritonavir in adults in some specific situations.
Croatian: Atazanavir Krka obično se daje s ritonavirom da pospješi njegovo djelovanje, no liječnici u odraslih mogu razmotriti prekid terapije ritonavirom u određenim situacijama.
English: The medicine is not expected to work in patients in whom many medicines in the same class as Atazanavir Krka (protease inhibitors) do not work.
Croatian: Ne očekuje se da će lijek djelovati u bolesnika u kojih ne djeluju brojni lijekovi iz istog razreda kao i Atazanavir Krka (inhibitori proteaze).
English: Atazanavir Krka does not cure HIV infection or AIDS but, when used in combination with other antivirals, it holds off the damage to the immune system and the development of infections and diseases associated with AIDS.
Croatian: Atazanavir Krka ne liječi infekciju HIV-om ni AIDS, ali kada se primjenjuje u kombinaciji s drugim protuvirusnim lijekovima, može odgoditi oštećenje imunosnog sustava te razvoj infekcija i bolesti povezanih s AIDSom.
English: This means that Atazanavir Krka contains the same active substance and works in the same way as a ‘reference medicine' already authorised in the EU called Reyataz.
Croatian: To znači da Atazanavir Krka sadrži istu djelatnu tvar i djeluje na jednak način kao i „referentni lijek” koji je već odobren u EU-u pod nazivom Reyataz.
English: Studies on the benefits and risks of the active substance in the authorised use have already been carried out with the reference medicine, Reyataz, and do not need to be repeated for Atazanavir Krka.
Croatian: Ispitivanja koristi i rizika djelatne tvari u odobrenoj primjeni već su provedena s referentnim lijekom Reyataz i stoga ih nije potrebno ponavljati za lijek Atazanavir Krka.
English: Doctors should prescribe Atazanavir Krka only after they have looked at which medicines the patient has taken and carried out tests to establish that the virus is likely to respond to Atazanavir Krka.
Croatian: Liječnici trebaju propisivati Atazanavir Krka tek nakon što su pregledali koje je lijekove bolesnik prethodno uzimao i proveli testiranja kojima se utvrđuje koliko je vjerojatno da će virus reagirati na Atazanavir Krka.
English: In younger patients, the dose of Atazanavir Krka depends on body weight.
Croatian: U mlađih bolesnika doza lijeka Atazanavir Krka ovisi o tjelesnoj težini.
English: Ritonavir slows down the break-down of atazanavir, increasing the levels of atazanavir in the blood.
Croatian: Ritonavir smanjuje stopu razgradnje atazanavira, čime se povećava razina atazanavira u krvi.
English: What measures are being taken to ensure the safe and effective use of Atazanavir Krka?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Atazanavir Krka?
English: Atazanavir Krka is an HIV medicine used to treat patients infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immunodeficiency syndrome (AIDS).
Croatian: Atazanavir Krka lijek je protiv HIV-a za liječenje osoba zaraženih virusom humane imunodeficijencije tipa 1 (HIV-1) koji uzrokuje sindrom stečene imunodeficijencije (AIDS).
English: The European Medicines Agency concluded that, in accordance with EU requirements, Atazanavir Krka has been shown to have comparable quality and to be bioequivalent to Reyataz.
Croatian: Europska agencija za lijekove zaključila je kako je, u skladu sa zahtjevima EU-a, potvrđeno da lijek Atazanavir Krka posjeduje usporedivu razinu kvalitete i da je bioekvivalentan lijeku Reyataz.
English: Side effects reported with Atazanavir Krka are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Atazanavir Krka pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: Because Atazanavir Krka is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Croatian: Budući da je Atazanavir Krka generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
English: It blocks an enzyme called protease, which is needed for the HIV virus to multiply.
Croatian: Djeluje blokiranjem enzima naziva proteaza, koji je virusu HIV-a potreban za umnožavanje.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Atazanavir Krka have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Atazanavir Krka nalaze se u sažetku opisa svojstava i u uputi o lijeku.
English: What are the benefits and risks of Atazanavir Krka?
Croatian: Koje su koristi i rizici od lijeka Atazanavir Krka?
English: For more information about using Atazanavir Krka, see the package leaflet or contact your doctor or pharmacist.
Croatian: Više informacija o primjeni lijeka Atazanavir Krka pročitajte u uputi o lijeku, odnosno obratite se liječniku ili ljekarniku.
English: An overview of Atazanavir Krka and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Atazanavir Krka i zašto je odobren u EU-u
English: Therefore, the Agency's view was that, as for Reyataz, the benefit of Atazanavir Krka outweighs the identified risk and it can be authorised for use in the EU.
Croatian: Stoga je stav Agencije da korist od lijeka Atazanavir Krka, kao i od lijeka Reyataz, nadmašuje identificirani rizik te da lijek može biti odobren za primjenu u EU-u.
English: The active substance in Atazanavir Krka, atazanavir, is a protease inhibitor.
Croatian: Djelatna tvar u lijeku Atazanavir Krka, atazanavir, inhibitor je proteaze.
English: Atazanavir Krka contains the active substance atazanavir and is a ‘generic medicine'.
Croatian: Atazanavir Krka sadrži djelatnu tvar atazanavir te je „generički lijek”.
English: Why is Atazanavir Krka authorised in the EU?
Croatian: Zašto je lijek Atazanavir Krka odobren u EU-u?
English: As for every medicine, the company provided studies on the quality of Atazanavir Krka.
Croatian: Kao za svaki lijek, tvrtka je dostavila podatke o ispitivanjima kakvoće za lijek Atazanavir Krka.
English: Other information about Atazanavir Krka
Croatian: Ostale informacije o lijeku Atazanavir Krka
English: As for all medicines, data on the use of Atazanavir Krka are continuously monitored.
Croatian: Kao i za sve lijekove, podatci o primjeni lijeka Atazanavir Krka kontinuirano se prate.
English: What is Atazanavir Krka and what is it used for?
Croatian: Što je Atazanavir Krka i za što se primjenjuje?
English: A small dose of another medicine, ritonavir, is normally given at the same time as a ‘booster'.
Croatian: Istodobno se obično daje mala doza drugog lijeka, ritonavira, da pospješi njegovo djelovanje.
English: Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Croatian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
English: Atazanavir Krka, taken in combination with other antiviral medicines, reduces the amount of HIV in the blood and keeps it at a low level.
Croatian: Kad se uzima u kombinaciji s drugim lijekovima protiv HIV-a, Atazanavir Krka smanjuje koncentraciju HIV-a u krvi i održava je na niskoj razini.
English: How does Atazanavir Krka work?
Croatian: Kako djeluje Atazanavir Krka?
English: How has Atazanavir Krka been studied?
Croatian: Kako je Atazanavir Krka ispitivan?
English: How is Atazanavir Krka used?
Croatian: Kako se Atazanavir Krka primjenjuje?
English: The Agency's Committee for Medicinal Products for Human Use (CHMP)
Croatian: Odbor za lijekove za humanu uporabu
English: The dose may be increased to 20 mg if the 10 mg dose is not effective.
Croatian: Doza se može povećati na 20 mg u slučaju da doza od 10 mg nije djelotvorna.
English: The full EPAR for Tadalafil Lilly can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za lijek Tadalafil Lilly nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: For erectile dysfunction, the usual dose is 10 mg at least 30 minutes before sexual activity.
Croatian: Za erektilnu disfunkciju uobičajena je doza od 10 mg koja se uzima barem 30 minuta prije seksualne aktivnosti.
English: Six of the studies included 1,328 patients who took the medicine before sexual activity.
Croatian: U šest ispitivanja sudjelovalo je 1 328 bolesnika koji su uzimali lijek prije seksualne aktivnosti.
English: The medicine should be taken around the same time every day and the need for the oncea-day dosing should be assessed regularly.
Croatian: Lijek treba uzimati otprilike u isto vrijeme svaki dan, a primjerenost doziranja ako se uzima jednom dnevno treba redoviti procjenjivati.
English: In men with benign prostatic hyperplasia, or both benign prostatic hyperplasia and erectile dysfunction, the recommended dose is 5 mg once a day.
Croatian: U muškaraca s benignom hiperplazijom prostate, ili s benignom hiperplazijom prostate i erektilnom disfunkcijom, preporučena doza iznosi 5 mg jedanput na dan.
English: Men who intend to use Tadalafil Lilly frequently (twice a week or more) can take a lower dose (5 or 2.5 mg) once a day, based on the doctor's judgement.
Croatian: Muškarci koji namjeravaju često uzimati Tadalafil Lilly (dvaput tjedno ili više) mogu uzimati nižu dozu lijeka (5 mg ili 2,5 mg) jedanput na dan, ovisno o prosudbi liječnika.
English: Results also reported improved erections with Tadalafil Lilly compared with those taking placebo.
Croatian: Rezultati su također zabilježili poboljšanja erekcije uz Tadalafil Lilly u usporedbi s ispitanicima koji su uzimali placebo.
English: The other three studies included 853 patients taking Tadalafil Lilly once a day at doses of 2.5 or 5 mg.
Croatian: U ostalim trima ispitivanjima sudjelovalo je 853 bolesnika koji su uzimali Tadalafil Lilly jedanput dnevno u dozama od 2,5 mg ili 5 mg.
English: Tadalafil Lilly contains the active substance tadalafil and is the same as Cialis, which is already authorised in the European Union (EU).
Croatian: Tadalafil Lilly sadrži djelatnu tvar tadalafil i isti je kao lijek Cialis, koji je već odobren u Europskoj uniji (EU).
English: Tadalafil Lilly is a medicine used to treat men with erectile dysfunction (sometimes called impotence).
Croatian: Tadafil Lilly je lijek za liječenje muškaraca s erektilnom disfunkcijom (ponekad zvanom impotencija).
English: Tadalafil Lilly must not be taken with nitrates (a type of medicine used for angina) or medicines of the class ‘guanylate cyclase stimulators' such as riociguat (a medicine for high blood pressure in the vessels supplying the lungs, known as pulmonary hypertension).
Croatian: Tadalafil Lilly se ne smije primjenjivati s nitratima (tipom lijeka koji se koristi za anginu) ili lijekovima klase "stimulatori gvanilat ciklaze" poput riocigvata (lijeka za visoki krvni tlak u krvnim žilama koje opskrbljuju pluća, poznat pod nazivom plućna hipertenzija).
English: All the studies compared Tadalafil Lilly with placebo (a dummy treatment) and measured improvements using questionnaires completed before and after treatment.
Croatian: U svim je ispitivanjima Tadalafil Lilly uspoređen s placebom (prividno liječenje), a poboljšanja su mjerena na temelju upitnika ispunjenih prije i nakon liječenja.
English: What is Tadalafil Lilly and what is it used for?
Croatian: Što je Tadalafil Lilly i za što se koristi?
English: This is a summary of the European public assessment report (EPAR) for Tadalafil Lilly.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) lijeka Tadalafil Lilly.
English: Tadalafil Lilly is available as tablets (2.5, 5, 10 and 20 mg) to be taken by mouth.
Croatian: Tadalafil Lilly dostupan je u obliku tableta (2,5 mg, 5 mg, 10 mg i 20 mg) koje se uzimaju kroz usta.
English: The company that makes Cialis has agreed that its scientific data can be used for Tadalafil Lilly (‘informed consent').
Croatian: Proizvođač lijeka Cialis pristao je da se njegovi znanstveni podatci koriste za lijek Tadalafil Lilly („informirani pristanak”).
English: The most common side effects with Tadalafil Lilly are headache, indigestion, back pain and muscle pain, which are more common at higher doses.
Croatian: Najčešće nuspojave lijeka Tadalafil Lilly su glavobolja, poremećaji probave, bol u leđima i mišićima, koje su uobičajenije u većim dozama.
English: Results for one of the questionnaires, in which men rated their condition on a scale of 0 (indicating severe erectile dysfunction) to 30 (no erectile dysfunction), showed that patients improved from about 15 before treatment, to 23 and 25 after treatment with Tadalafil Lilly 10 and 20 mg, respectively.
Croatian: Rezultati jednog upitnika u kojemu su muškarci ocjenjivali svoje stanje na ljestvici od 0 (teška erektilna disfunkcija) do 30 (bez erektilne disfunkcije) pokazali su da se stanje bolesnika poboljšalo od otprilike ocjene 15 prije liječenja do 23, odnosno 25 nakon primjene lijeka Tadalafil Lilly od 10 mg, odnosno od 20 mg.
English: It must also not be taken by patients who have ever had loss of vision in one eye because of a problem with blood flow to the nerve in the eye (non-arteritic anterior ischemic optic neuropathy, NAION).
Croatian: Lijek također ne smiju uzimati bolesnici koji su izgubili vid na jednom oku zbog problema s dotokom krvi u očni živac (nearterijska prednja ishemijska optička neuropatija, NAION).
English: What measures are being taken to ensure the safe and effective use of Tadalafil Lilly?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Tadalafil Lilly?
English: The active substance of Tadalafil Lilly, tadalafil, belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors.
Croatian: Tadalafil, djelatna tvar lijeka Tadalafil Lilly, pripada skupini lijekova zvanih inhibitori fosfodiesteraze tipa 5 (PDE5).
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Tadalafil Lilly have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Tadalafil Lilly nalaze se u sažetku opisa svojstava i u uputi o lijeku.
English: This may reduce the problems with the flow of urine which are symptoms of benign prostatic hyperplasia.
Croatian: Time se mogu ublažiti problemi s protokom urina, što je simptom benigne hiperplazije prostate.
English: In four main studies involving 1,500 patients, some of whom also had erectile dysfunction, patients taking Tadalafil Lilly at a dose of 5 mg had greater reductions in IPSS (4.8 to 6.3 points) after 12 weeks than those taking placebo (2.2 to 4.4 points).
Croatian: U četirima glavnim ispitivanjima u kojima je sudjelovalo 1 500 bolesnika, od kojih su neki imali i erektilnu disfunkciju, pokazalo se da su se nakon 12 tjedana vrijednosti prema IPSS-u u znatno većoj mjeri smanjile u bolesnika koji su uzimali Tadalafil Lilly u dozi od 5 mg (s 4,8 na 6,3 bodova) nego u onih koji su uzimali placebo (s 2,2 na 4,4 boda).
English: Tadalafil Lilly has also been shown to improve the symptoms of benign prostatic hyperplasia as measured using the international prostate symptom score (IPSS), which ranges from 0 (no symptoms) to 35 (severe symptoms).
Croatian: Također je utvrđeno da Tadalafil Lilly ublažava simptome benigne hiperplazije prostate koji su mjereni s pomoću međunarodne ljestvice simptoma prostatizma (IPSS) čiji je raspon od 0 (bez simptoma) do 35 (ozbiljni simptomi).
English: During normal sexual stimulation, cGMP is produced in the penis, where it causes the muscle in the spongy tissue of the penis (the corpora cavernosa) to relax, allowing the flow of blood into the corpora, producing the erection.
Croatian: Tijekom normalne seksualne stimulacije, u penisu se stvara cGMP i uzrokuje opuštanje mišića spužvastog tkiva penisa (corpora cavernosa) što omogućava protok krvi u tkivo i tako nastaje erekcija.
English: Tadalafil Lilly must not be used in men with certain cardiovascular (heart and blood vessel) conditions or when sexual activity is inadvisable.
Croatian: Tadalafil Lilly ne smiju primjenjivati muškarci s određenim kardiovaskularnim bolestima (bolesti srca i krvnih žila) ili oni kojima se ne preporučuje seksualna aktivnost.
English: For more information about treatment with Tadalafil Lilly, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o liječenju lijekom Tadalafil Lilly pročitajte u uputi o lijeku (također dio EPAR-a), odnosno obratite se svom liječniku ili ljekarniku.
English: As shown in studies, Tadalafil Lilly is effective at improving the ability to get and maintain erections and at relieving the symptoms of benign prostatic hyperplasia.
Croatian: Kako je utvrđeno u ispitivanjima, Tadalafil Lilly djeluje na poboljšanje sposobnosti postizanja i održavanja erekcije te na ublažavanju simptoma benigne hiperplazije prostate.
English: What are the risks associated with Tadalafil Lilly?
Croatian: Koji su rizici povezani s lijekom Tadalafil Lilly?
English: It is not intended to provide practical advice on how to use Tadalafil Lilly.
Croatian: Svrha sažetka nije davati praktične savjete o primjeni lijeka Tadalafil Lilly.
English: By blocking the breakdown of cGMP, Tadalafil Lilly restores erectile function during sexual stimulation and also improves the blood flow to, and relaxes the muscles of, the prostate and bladder.
Croatian: Blokirajući razgradnju cGMP-a, Tadalafil Lilly obnavlja erektilnu funkciju tijekom seksualne stimulacije te ujedno poboljšava dotok krvi u prostatu i mjehur te im opušta mišiće.
English: It can also be used in men to treat the signs and symptoms of benign prostatic hyperplasia (enlarged prostate gland that is not cancerous, which leads to problems with the flow of urine).
Croatian: Također se primjenjuje u muškaraca za liječenje znakova i simptoma benigne hiperplazije prostate (dobroćudno povećanje prostate koje uzrokuje probleme s protokom urina).
English: For practical information about using Tadalafil Lilly, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o primjeni lijeka Tadalafil Lilly bolesnici trebaju pročitati u uputi o lijeku, odnosno obratiti se svom liječniku ili ljekarniku.
English: Other information about Tadalafil Lilly
Croatian: Ostale informacije o lijeku Tadalafil Lilly
English: What benefits of Tadalafil Lilly have been shown in studies?
Croatian: Koje su koristi od lijeka Tadalafil Lilly dokazane u ispitivanjima?
English: Why is Tadalafil Lilly approved?
Croatian: Zašto je lijek Tadalafil Lilly odobren?
English: therefore concluded that Tadalafil Lilly's benefits are greater than its risks and recommended that it be approved for use in the EU.
Croatian: (CHMP) pri Agenciji odlučio je da koristi od lijeka Tadalafil Lilly nadmašuju s njim povezane rizike te je preporučio njegovo odobrenje za primjenu u Europskoj uniji.
English: The side effects seen with the medicine are considered manageable.
Croatian: Smatra se da je moguće kontrolirati nuspojave zabilježene pri primjeni lijeka.
English: How is Tadalafil Lilly used?
Croatian: Kako se Tadalafil Lilly koristi?
English: How does Tadalafil Lilly work?
Croatian: Kako djeluje Tadalafil Lilly?
English: For the full list of all side effects with Tadalafil Lilly, see the package leaflet.
Croatian: Potpuni popis nuspojava zabilježenih pri primjeni lijeka Tadalafil Lilly potražite u uputi o lijeku.
English: Tadalafil Lilly has been shown to improve the ability to get and maintain an erection in nine main studies involving over 2,000 men with erectile dysfunction.
Croatian: U devet glavnih ispitivanja u kojima je sudjelovalo preko 2 000 muškaraca s erektilnom disfunkcijom pokazalo se da Tadalafil Lilly dovodi do poboljšanja sposobnosti postizanja i održavanja erekcije.
English: Missing values were considered a non-response.
Croatian: Vrijednosti koje nedostaju smatrale su se kao nedostatak odgovora.